BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robak P, Dróżdż I, Jarych D, Mikulski D, Węgłowska E, Siemieniuk-Ryś M, Misiewicz M, Stawiski K, Fendler W, Szemraj J, Smolewski P, Robak T. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients. Cancers (Basel) 2020;12:E2569. [PMID: 32916955 DOI: 10.3390/cancers12092569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Königstein K, Meier J, Angst T, Maurer DJ, Kröpfl JM, Carrard J, Infanger D, Baumann S, Bischofsberger I, Harder M, Jäggi Y, Wettach S, Hanssen H, Schmidt-Trucksäss A. VascuFit: vascular effects of non-linear periodized exercise training in sedentary adults with elevated cardiovascular risk - protocol for a randomized controlled trial. BMC Cardiovasc Disord 2022;22:449. [PMID: 36303113 DOI: 10.1186/s12872-022-02905-1] [Reference Citation Analysis]
2 Pawlik B, Grabia S, Smyczyńska U, Fendler W, Dróżdż I, Liszewska E, Jaworski J, Kotulska K, Jóźwiak S, Młynarski W, Trelińska J. MicroRNA expression profile in TSC cell lines and the impact of mTOR inhibitor.. [DOI: 10.21203/rs.3.rs-2027981/v1] [Reference Citation Analysis]
3 Dong X, Lu G, Su X, Liu J, Chen X, Tian Y, Chang Y, Wang L, Wang W, Zhou J. Identification of key miRNA signature and pathways involved in multiple myeloma by integrated bioinformatics analysis. Hematology 2021;26:976-84. [PMID: 34871535 DOI: 10.1080/16078454.2021.2003980] [Reference Citation Analysis]
4 Robak P, Szemraj J, Mikulski D, Drozdz I, Juszczak K, Jarych D, Misiewicz M, Kościelny K, Fendler W, Robak T. Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. J Clin Med 2021;10:5028. [PMID: 34768548 DOI: 10.3390/jcm10215028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lutsenko A, Belaya Z, Nikitin A, Solodovnikov A, Lapshina A, Koshkin P, Vorontsova M, Rozhinskaya L, Melnichenko G, Dedov I. Circulating plasma MicroRNA in patients with active acromegaly. J Clin Endocrinol Metab 2021:dgab695. [PMID: 34550352 DOI: 10.1210/clinem/dgab695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yuan J, Zhang Q, Wu S, Yan S, Zhao R, Sun Y, Tian X, Zhou K. miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK/Nf-κb signaling pathway in mantle cell lymphoma. Exp Hematol 2021;103:52-59.e2. [PMID: 34474146 DOI: 10.1016/j.exphem.2021.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Xiang Y, Zhang L, Xiang P, Zhang J. Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations. Front Oncol 2021;11:698197. [PMID: 34307166 DOI: 10.3389/fonc.2021.698197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Łuczkowska K, Rogińska D, Ulańczyk Z, Safranow K, Paczkowska E, Baumert B, Milczarek S, Osękowska B, Górska M, Borowiecka E, Sommerfeld K, Zawodny P, Szudy-Szczyrek A, Hus M, Machaliński B. microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. Leuk Lymphoma 2021;:1-9. [PMID: 34092168 DOI: 10.1080/10428194.2021.1933478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Katiyar A, Kaur G, Rani L, Jena L, Singh H, Kumar L, Sharma A, Kaur P, Gupta R. Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data. Sci Rep 2021;11:10957. [PMID: 34040057 DOI: 10.1038/s41598-021-90424-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Robak P, Jarych D, Mikulski D, Dróżdż I, Węgłowska E, Kotkowska A, Misiewicz M, Smolewski P, Stawiski K, Fendler W, Szemraj J, Robak T. The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib. Cancers (Basel) 2021;13:951. [PMID: 33668794 DOI: 10.3390/cancers13050951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Allegra A, Ettari R, Innao V, Bitto A. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma. Cells 2021;10:448. [PMID: 33672466 DOI: 10.3390/cells10020448] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
12 Robak T. Meet Our Editorial Board Member. CMC 2020;28:211-2. [DOI: 10.2174/092986732802201230094642] [Reference Citation Analysis]